Anti-Human LILRB3/CD85a Rabbit Recombinant Antibody, PBS Only

LILRB3/CD85a Uni-rAbTM Recombinant Antibody for FC
Cat No. 98237-1-PBS

Print datasheet

CloneNo. 241894C10

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

FC

LILRB3, ILT-5, ILT5, HL9, CD85a

Formulation:  PBS Only
PBS and Azide
PBS Only
Conjugate:  Unconjugated
Size: 

-/ -


产品信息

98237-1-PBS targets LILRB3/CD85a in FC applications and shows reactivity with human samples.

Tested Applications FC Application Description
Tested Reactivity human
Immunogen Recombinant protein 种属同源性预测
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Full Name leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3
Synonyms LILRB3, ILT-5, ILT5, HL9, CD85a
Calculated Molecular Weight 631 aa, 69 kDa
GenBank Accession NumberBC112198
Gene Symbol LILRB3
Gene ID (NCBI) 11025
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purfication
UNIPROT IDO75022
Storage Buffer PBS Only
Storage ConditionsStore at -80°C.
The product is shipped with ice packs. Upon receipt, store it immediately at -80°C

背景介绍

The leukocyte immunoglobulin-like receptors (LIRs, also known as ILTs, CD85, and LILRs) comprise a family of related immunoregulatory receptors encoded within the leukocyte receptor cluster (LRC) at chromosomal region 19q13.4 (PMID: 11491530). LIRs are transmembrane proteins containing either two or four extracellular immunoglobulin domains, and have diverse functions, including the regulation of inflammation, immune tolerance, cell differentiation and nervous system plasticity (PMID: 16406677; 26040207). LILRB3, also known as ILT-5 or CD85a, belongs to the subfamily B class of LIR receptors which contain two or four extracellular immunoglobulin domains, a transmembrane domain, and two to four cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). LILRB3 is found on the surface of a variety of cell types including monocytes/macrophages, granulocytes, NK cells and some T cells. It binds to MHC class I molecules and transduces a negative signal that inhibits stimulation of an immune response. LILRB3 has been reported as a myeloid cell checkpoint that elicits profound immunomodulation (PMID: 32870822).

Loading...